Ainos, Inc. (AIMD)
NASDAQ: AIMD · Real-Time Price · USD
0.5000
+0.0088 (1.79%)
Apr 1, 2025, 10:21 AM EDT - Market open
Ainos Revenue
In the year 2024, Ainos had annual revenue of $20.73K, down -83.02%.
Revenue (ttm)
$20.73K
Revenue Growth
-83.02%
P/S Ratio
225.22
Revenue / Employee
$471
Employees
44
Market Cap
7.72M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 20.73K | -101.38K | -83.02% |
| Dec 31, 2023 | 122.11K | -3.40M | -96.53% |
| Dec 31, 2022 | 3.52M | 2.93M | 491.97% |
| Dec 31, 2021 | 594.56K | 578.00K | 3,489.71% |
| Dec 31, 2020 | 16.56K | 4.83K | 41.19% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 400.28B |
| Johnson & Johnson | 88.82B |
| Merck & Co. | 64.17B |
| AbbVie | 56.33B |
| AstraZeneca | 54.07B |
| Novartis AG | 51.72B |
| Eli Lilly and Company | 45.04B |
| Thermo Fisher Scientific | 42.88B |
AIMD News
- 7 days ago - Ainos to Participate in Fireside Chat with Water Tower Research on April 8, 2025 - Accesswire
- 19 days ago - Water Tower Research Spotlights Ainos & ASE Partnership: Unleashing AI Nose's Potential in Chip Manufacturing and More - Accesswire
- 21 days ago - Ainos and ASE Partner to Power AI Scent Digitization in Semiconductor Manufacturing - Accesswire
- 24 days ago - Ainos Reports Full Year 2024 Financial Results - Accesswire
- 24 days ago - Water Tower Research Highlights Ainos & ugo Partnership: The Final Sense for Robots - AI Smell is Here - Accesswire
- 26 days ago - Ainos and ugo to Develop the World's First Robot With a Sense of Smell - Accesswire
- 2 months ago - Ainos Achieves Major Breakthrough: Japan Patent Approval for VELDONA Redefines Antiviral Innovation - Accesswire
- 2 months ago - Water Tower Research Spotlights Ainos' AI Nose Programs and Strategic Milestones for 2025 - Accesswire